nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—Alzheimer's disease	0.208	0.522	CbGaD
Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.19	0.478	CbGaD
Cyclobenzaprine—HTR2A—Donepezil—Alzheimer's disease	0.162	0.388	CbGbCtD
Cyclobenzaprine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0676	0.161	CbGbCtD
Cyclobenzaprine—CYP2D6—Donepezil—Alzheimer's disease	0.054	0.129	CbGbCtD
Cyclobenzaprine—CYP3A4—Rivastigmine—Alzheimer's disease	0.043	0.103	CbGbCtD
Cyclobenzaprine—CYP2D6—Galantamine—Alzheimer's disease	0.0348	0.0832	CbGbCtD
Cyclobenzaprine—CYP3A4—Donepezil—Alzheimer's disease	0.0344	0.0821	CbGbCtD
Cyclobenzaprine—CYP3A4—Galantamine—Alzheimer's disease	0.0221	0.0529	CbGbCtD
Cyclobenzaprine—HTR2A—choroid plexus—Alzheimer's disease	0.0083	0.304	CbGeAlD
Cyclobenzaprine—HTR2A—locus ceruleus—Alzheimer's disease	0.00513	0.188	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00418	0.153	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00243	0.089	CbGeAlD
Cyclobenzaprine—HTR2A—blood vessel—Alzheimer's disease	0.0012	0.044	CbGeAlD
Cyclobenzaprine—Olopatadine—S100B—Alzheimer's disease	0.000775	0.175	CrCbGaD
Cyclobenzaprine—HTR2A—embryo—Alzheimer's disease	0.000718	0.0263	CbGeAlD
Cyclobenzaprine—HTR2A—forebrain—Alzheimer's disease	0.000635	0.0232	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalon—Alzheimer's disease	0.000584	0.0214	CbGeAlD
Cyclobenzaprine—CYP2D6—forebrain—Alzheimer's disease	0.000579	0.0212	CbGeAlD
Cyclobenzaprine—CYP2D6—telencephalon—Alzheimer's disease	0.000532	0.0195	CbGeAlD
Cyclobenzaprine—Dimetacrine—ACHE—Alzheimer's disease	0.000448	0.101	CrCbGaD
Cyclobenzaprine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000448	0.00307	CcSEcCtD
Cyclobenzaprine—Ataxia—Rivastigmine—Alzheimer's disease	0.000443	0.00304	CcSEcCtD
Cyclobenzaprine—Tinnitus—Galantamine—Alzheimer's disease	0.000441	0.00303	CcSEcCtD
Cyclobenzaprine—Gastritis—Memantine—Alzheimer's disease	0.000426	0.00292	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Donepezil—Alzheimer's disease	0.000423	0.0029	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Galantamine—Alzheimer's disease	0.000423	0.0029	CcSEcCtD
Cyclobenzaprine—Weight increased—Donepezil—Alzheimer's disease	0.000417	0.00286	CcSEcCtD
Cyclobenzaprine—Gastritis—Rivastigmine—Alzheimer's disease	0.000417	0.00286	CcSEcCtD
Cyclobenzaprine—Flatulence—Galantamine—Alzheimer's disease	0.000406	0.00278	CcSEcCtD
Cyclobenzaprine—Tension—Galantamine—Alzheimer's disease	0.000404	0.00277	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Galantamine—Alzheimer's disease	0.000403	0.00277	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000403	0.00276	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000401	0.00275	CcSEcCtD
Cyclobenzaprine—Nervousness—Galantamine—Alzheimer's disease	0.0004	0.00274	CcSEcCtD
Cyclobenzaprine—Jaundice—Donepezil—Alzheimer's disease	0.000398	0.00273	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Memantine—Alzheimer's disease	0.000395	0.00271	CcSEcCtD
Cyclobenzaprine—Sweating—Donepezil—Alzheimer's disease	0.000392	0.00269	CcSEcCtD
Cyclobenzaprine—Vision blurred—Galantamine—Alzheimer's disease	0.000388	0.00266	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000387	0.00265	CcSEcCtD
Cyclobenzaprine—Tremor—Galantamine—Alzheimer's disease	0.000386	0.00265	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Memantine—Alzheimer's disease	0.000384	0.00264	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000383	0.00263	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000382	0.00262	CcSEcCtD
Cyclobenzaprine—Weight increased—Memantine—Alzheimer's disease	0.000379	0.0026	CcSEcCtD
Cyclobenzaprine—Agitation—Galantamine—Alzheimer's disease	0.000379	0.0026	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000378	0.00259	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000376	0.00258	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000375	0.00257	CcSEcCtD
Cyclobenzaprine—Malaise—Galantamine—Alzheimer's disease	0.000372	0.00255	CcSEcCtD
Cyclobenzaprine—Weight increased—Rivastigmine—Alzheimer's disease	0.00037	0.00254	CcSEcCtD
Cyclobenzaprine—Vertigo—Galantamine—Alzheimer's disease	0.00037	0.00254	CcSEcCtD
Cyclobenzaprine—Syncope—Galantamine—Alzheimer's disease	0.00037	0.00253	CcSEcCtD
Cyclobenzaprine—Hepatitis—Donepezil—Alzheimer's disease	0.000367	0.00252	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000366	0.00251	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000365	0.0025	CcSEcCtD
Cyclobenzaprine—Hallucination—Donepezil—Alzheimer's disease	0.000365	0.0025	CcSEcCtD
Cyclobenzaprine—Palpitations—Galantamine—Alzheimer's disease	0.000364	0.0025	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Donepezil—Alzheimer's disease	0.000364	0.0025	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000364	0.00249	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Memantine—Alzheimer's disease	0.000364	0.00249	CcSEcCtD
Cyclobenzaprine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000363	0.00249	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000362	0.00248	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000358	0.00245	CcSEcCtD
Cyclobenzaprine—Convulsion—Galantamine—Alzheimer's disease	0.000357	0.00245	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000356	0.00244	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000356	0.00244	CcSEcCtD
Cyclobenzaprine—Hypertension—Galantamine—Alzheimer's disease	0.000356	0.00244	CcSEcCtD
Cyclobenzaprine—Chest pain—Galantamine—Alzheimer's disease	0.000351	0.00241	CcSEcCtD
Cyclobenzaprine—Myalgia—Galantamine—Alzheimer's disease	0.000351	0.00241	CcSEcCtD
Cyclobenzaprine—Anxiety—Galantamine—Alzheimer's disease	0.00035	0.0024	CcSEcCtD
Cyclobenzaprine—Sweating—Rivastigmine—Alzheimer's disease	0.000348	0.00239	CcSEcCtD
Cyclobenzaprine—Discomfort—Galantamine—Alzheimer's disease	0.000347	0.00238	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Memantine—Alzheimer's disease	0.000346	0.00237	CcSEcCtD
Cyclobenzaprine—HTR2A—nervous system—Alzheimer's disease	0.000345	0.0126	CbGeAlD
Cyclobenzaprine—Dry mouth—Galantamine—Alzheimer's disease	0.000343	0.00235	CcSEcCtD
Cyclobenzaprine—Tinnitus—Donepezil—Alzheimer's disease	0.000342	0.00235	CcSEcCtD
Cyclobenzaprine—Confusional state—Galantamine—Alzheimer's disease	0.000339	0.00233	CcSEcCtD
Cyclobenzaprine—Hepatitis—Memantine—Alzheimer's disease	0.000333	0.00228	CcSEcCtD
Cyclobenzaprine—HTR2A—central nervous system—Alzheimer's disease	0.000332	0.0121	CbGeAlD
Cyclobenzaprine—Hallucination—Memantine—Alzheimer's disease	0.000331	0.00227	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000331	0.00227	CcSEcCtD
Cyclobenzaprine—Shock—Galantamine—Alzheimer's disease	0.000331	0.00227	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Memantine—Alzheimer's disease	0.000331	0.00227	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000329	0.00226	CcSEcCtD
Cyclobenzaprine—Tachycardia—Galantamine—Alzheimer's disease	0.000328	0.00225	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Donepezil—Alzheimer's disease	0.000328	0.00225	CcSEcCtD
Cyclobenzaprine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000326	0.00223	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000325	0.00223	CcSEcCtD
Cyclobenzaprine—HTR2A—cerebellum—Alzheimer's disease	0.000324	0.0119	CbGeAlD
Cyclobenzaprine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000324	0.00222	CcSEcCtD
Cyclobenzaprine—Hallucination—Rivastigmine—Alzheimer's disease	0.000324	0.00222	CcSEcCtD
Cyclobenzaprine—Alopecia—Donepezil—Alzheimer's disease	0.000324	0.00222	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000323	0.00222	CcSEcCtD
Cyclobenzaprine—Anorexia—Galantamine—Alzheimer's disease	0.000321	0.0022	CcSEcCtD
Cyclobenzaprine—CYP3A4—nervous system—Alzheimer's disease	0.000319	0.0117	CbGeAlD
Cyclobenzaprine—Flatulence—Donepezil—Alzheimer's disease	0.000315	0.00216	CcSEcCtD
Cyclobenzaprine—Hypotension—Galantamine—Alzheimer's disease	0.000314	0.00215	CcSEcCtD
Cyclobenzaprine—CYP2D6—nervous system—Alzheimer's disease	0.000314	0.0115	CbGeAlD
Cyclobenzaprine—Tension—Donepezil—Alzheimer's disease	0.000313	0.00215	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Donepezil—Alzheimer's disease	0.000313	0.00214	CcSEcCtD
Cyclobenzaprine—Tinnitus—Memantine—Alzheimer's disease	0.000311	0.00213	CcSEcCtD
Cyclobenzaprine—Nervousness—Donepezil—Alzheimer's disease	0.00031	0.00213	CcSEcCtD
Cyclobenzaprine—CYP3A4—central nervous system—Alzheimer's disease	0.000307	0.0112	CbGeAlD
Cyclobenzaprine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000306	0.0021	CcSEcCtD
Cyclobenzaprine—Insomnia—Galantamine—Alzheimer's disease	0.000304	0.00209	CcSEcCtD
Cyclobenzaprine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000304	0.00208	CcSEcCtD
Cyclobenzaprine—CYP2D6—central nervous system—Alzheimer's disease	0.000302	0.0111	CbGeAlD
Cyclobenzaprine—Paraesthesia—Galantamine—Alzheimer's disease	0.000302	0.00207	CcSEcCtD
Cyclobenzaprine—Vision blurred—Donepezil—Alzheimer's disease	0.000301	0.00206	CcSEcCtD
Cyclobenzaprine—Tremor—Donepezil—Alzheimer's disease	0.000299	0.00205	CcSEcCtD
Cyclobenzaprine—Somnolence—Galantamine—Alzheimer's disease	0.000299	0.00205	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Memantine—Alzheimer's disease	0.000298	0.00204	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000296	0.00203	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Galantamine—Alzheimer's disease	0.000296	0.00203	CcSEcCtD
Cyclobenzaprine—CYP2D6—cerebellum—Alzheimer's disease	0.000296	0.0108	CbGeAlD
Cyclobenzaprine—Alopecia—Memantine—Alzheimer's disease	0.000294	0.00202	CcSEcCtD
Cyclobenzaprine—Agitation—Donepezil—Alzheimer's disease	0.000293	0.00201	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Galantamine—Alzheimer's disease	0.000292	0.002	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000291	0.002	CcSEcCtD
Cyclobenzaprine—Fatigue—Galantamine—Alzheimer's disease	0.00029	0.00199	CcSEcCtD
Cyclobenzaprine—Malaise—Donepezil—Alzheimer's disease	0.000288	0.00197	CcSEcCtD
Cyclobenzaprine—Alopecia—Rivastigmine—Alzheimer's disease	0.000288	0.00197	CcSEcCtD
Cyclobenzaprine—Constipation—Galantamine—Alzheimer's disease	0.000288	0.00197	CcSEcCtD
Cyclobenzaprine—Vertigo—Donepezil—Alzheimer's disease	0.000287	0.00197	CcSEcCtD
Cyclobenzaprine—Syncope—Donepezil—Alzheimer's disease	0.000286	0.00196	CcSEcCtD
Cyclobenzaprine—Flatulence—Memantine—Alzheimer's disease	0.000286	0.00196	CcSEcCtD
Cyclobenzaprine—Tension—Memantine—Alzheimer's disease	0.000285	0.00195	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Memantine—Alzheimer's disease	0.000284	0.00195	CcSEcCtD
Cyclobenzaprine—Nervousness—Memantine—Alzheimer's disease	0.000282	0.00193	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000281	0.00192	CcSEcCtD
Cyclobenzaprine—Flatulence—Rivastigmine—Alzheimer's disease	0.000279	0.00192	CcSEcCtD
Cyclobenzaprine—Tension—Rivastigmine—Alzheimer's disease	0.000278	0.00191	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000278	0.0019	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000277	0.0019	CcSEcCtD
Cyclobenzaprine—Amitriptyline—NTRK2—Alzheimer's disease	0.000277	0.0626	CrCbGaD
Cyclobenzaprine—Convulsion—Donepezil—Alzheimer's disease	0.000277	0.0019	CcSEcCtD
Cyclobenzaprine—Hypertension—Donepezil—Alzheimer's disease	0.000276	0.00189	CcSEcCtD
Cyclobenzaprine—Nervousness—Rivastigmine—Alzheimer's disease	0.000275	0.00189	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000275	0.00189	CcSEcCtD
Cyclobenzaprine—Vision blurred—Memantine—Alzheimer's disease	0.000273	0.00187	CcSEcCtD
Cyclobenzaprine—Myalgia—Donepezil—Alzheimer's disease	0.000272	0.00186	CcSEcCtD
Cyclobenzaprine—Chest pain—Donepezil—Alzheimer's disease	0.000272	0.00186	CcSEcCtD
Cyclobenzaprine—Tremor—Memantine—Alzheimer's disease	0.000272	0.00186	CcSEcCtD
Cyclobenzaprine—Anxiety—Donepezil—Alzheimer's disease	0.000271	0.00186	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000269	0.00184	CcSEcCtD
Cyclobenzaprine—Discomfort—Donepezil—Alzheimer's disease	0.000269	0.00184	CcSEcCtD
Cyclobenzaprine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000267	0.00183	CcSEcCtD
Cyclobenzaprine—Agitation—Memantine—Alzheimer's disease	0.000266	0.00183	CcSEcCtD
Cyclobenzaprine—Dry mouth—Donepezil—Alzheimer's disease	0.000266	0.00182	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Galantamine—Alzheimer's disease	0.000266	0.00182	CcSEcCtD
Cyclobenzaprine—Tremor—Rivastigmine—Alzheimer's disease	0.000266	0.00182	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HTR6—Alzheimer's disease	0.000265	0.06	CrCbGaD
Cyclobenzaprine—HTR2A—brain—Alzheimer's disease	0.000264	0.00964	CbGeAlD
Cyclobenzaprine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000263	0.0018	CcSEcCtD
Cyclobenzaprine—Confusional state—Donepezil—Alzheimer's disease	0.000263	0.0018	CcSEcCtD
Cyclobenzaprine—Malaise—Memantine—Alzheimer's disease	0.000261	0.00179	CcSEcCtD
Cyclobenzaprine—Agitation—Rivastigmine—Alzheimer's disease	0.000261	0.00179	CcSEcCtD
Cyclobenzaprine—Oedema—Donepezil—Alzheimer's disease	0.000261	0.00179	CcSEcCtD
Cyclobenzaprine—Vertigo—Memantine—Alzheimer's disease	0.00026	0.00179	CcSEcCtD
Cyclobenzaprine—Syncope—Memantine—Alzheimer's disease	0.00026	0.00178	CcSEcCtD
Cyclobenzaprine—Leukopenia—Memantine—Alzheimer's disease	0.00026	0.00178	CcSEcCtD
Cyclobenzaprine—Shock—Donepezil—Alzheimer's disease	0.000256	0.00176	CcSEcCtD
Cyclobenzaprine—Palpitations—Memantine—Alzheimer's disease	0.000256	0.00176	CcSEcCtD
Cyclobenzaprine—Malaise—Rivastigmine—Alzheimer's disease	0.000256	0.00175	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000255	0.00175	CcSEcCtD
Cyclobenzaprine—Vertigo—Rivastigmine—Alzheimer's disease	0.000255	0.00175	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Memantine—Alzheimer's disease	0.000255	0.00175	CcSEcCtD
Cyclobenzaprine—Syncope—Rivastigmine—Alzheimer's disease	0.000254	0.00174	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000252	0.00173	CcSEcCtD
Cyclobenzaprine—Convulsion—Memantine—Alzheimer's disease	0.000251	0.00172	CcSEcCtD
Cyclobenzaprine—Palpitations—Rivastigmine—Alzheimer's disease	0.000251	0.00172	CcSEcCtD
Cyclobenzaprine—Hypertension—Memantine—Alzheimer's disease	0.00025	0.00172	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000249	0.00171	CcSEcCtD
Cyclobenzaprine—Anorexia—Donepezil—Alzheimer's disease	0.000248	0.0017	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000248	0.0017	CcSEcCtD
Cyclobenzaprine—Chest pain—Memantine—Alzheimer's disease	0.000247	0.00169	CcSEcCtD
Cyclobenzaprine—Myalgia—Memantine—Alzheimer's disease	0.000247	0.00169	CcSEcCtD
Cyclobenzaprine—Anxiety—Memantine—Alzheimer's disease	0.000246	0.00169	CcSEcCtD
Cyclobenzaprine—Convulsion—Rivastigmine—Alzheimer's disease	0.000246	0.00169	CcSEcCtD
Cyclobenzaprine—Hypertension—Rivastigmine—Alzheimer's disease	0.000245	0.00168	CcSEcCtD
Cyclobenzaprine—Discomfort—Memantine—Alzheimer's disease	0.000244	0.00167	CcSEcCtD
Cyclobenzaprine—Hypotension—Donepezil—Alzheimer's disease	0.000244	0.00167	CcSEcCtD
Cyclobenzaprine—Chest pain—Rivastigmine—Alzheimer's disease	0.000241	0.00166	CcSEcCtD
Cyclobenzaprine—Myalgia—Rivastigmine—Alzheimer's disease	0.000241	0.00166	CcSEcCtD
Cyclobenzaprine—Dry mouth—Memantine—Alzheimer's disease	0.000241	0.00166	CcSEcCtD
Cyclobenzaprine—Asthenia—Galantamine—Alzheimer's disease	0.000241	0.00165	CcSEcCtD
Cyclobenzaprine—Anxiety—Rivastigmine—Alzheimer's disease	0.000241	0.00165	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—Alzheimer's disease	0.00024	0.00878	CbGeAlD
Cyclobenzaprine—Confusional state—Memantine—Alzheimer's disease	0.000239	0.00164	CcSEcCtD
Cyclobenzaprine—Discomfort—Rivastigmine—Alzheimer's disease	0.000239	0.00164	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000237	0.00163	CcSEcCtD
Cyclobenzaprine—Oedema—Memantine—Alzheimer's disease	0.000237	0.00162	CcSEcCtD
Cyclobenzaprine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000236	0.00162	CcSEcCtD
Cyclobenzaprine—Insomnia—Donepezil—Alzheimer's disease	0.000236	0.00162	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Donepezil—Alzheimer's disease	0.000234	0.0016	CcSEcCtD
Cyclobenzaprine—Confusional state—Rivastigmine—Alzheimer's disease	0.000233	0.0016	CcSEcCtD
Cyclobenzaprine—Shock—Memantine—Alzheimer's disease	0.000233	0.0016	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Donepezil—Alzheimer's disease	0.000232	0.00159	CcSEcCtD
Cyclobenzaprine—Somnolence—Donepezil—Alzheimer's disease	0.000232	0.00159	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000232	0.00159	CcSEcCtD
Cyclobenzaprine—Oedema—Rivastigmine—Alzheimer's disease	0.000231	0.00159	CcSEcCtD
Cyclobenzaprine—Tachycardia—Memantine—Alzheimer's disease	0.000231	0.00158	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Galantamine—Alzheimer's disease	0.00023	0.00158	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Donepezil—Alzheimer's disease	0.000229	0.00157	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000229	0.00157	CcSEcCtD
Cyclobenzaprine—Shock—Rivastigmine—Alzheimer's disease	0.000228	0.00156	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000227	0.00155	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Donepezil—Alzheimer's disease	0.000227	0.00155	CcSEcCtD
Cyclobenzaprine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000226	0.00155	CcSEcCtD
Cyclobenzaprine—Anorexia—Memantine—Alzheimer's disease	0.000226	0.00155	CcSEcCtD
Cyclobenzaprine—Fatigue—Donepezil—Alzheimer's disease	0.000225	0.00154	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000224	0.00153	CcSEcCtD
Cyclobenzaprine—Constipation—Donepezil—Alzheimer's disease	0.000223	0.00153	CcSEcCtD
Cyclobenzaprine—Dizziness—Galantamine—Alzheimer's disease	0.000222	0.00153	CcSEcCtD
Cyclobenzaprine—Hypotension—Memantine—Alzheimer's disease	0.000221	0.00152	CcSEcCtD
Cyclobenzaprine—Anorexia—Rivastigmine—Alzheimer's disease	0.000221	0.00151	CcSEcCtD
Cyclobenzaprine—Hypotension—Rivastigmine—Alzheimer's disease	0.000216	0.00148	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000216	0.00148	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000215	0.00147	CcSEcCtD
Cyclobenzaprine—Insomnia—Memantine—Alzheimer's disease	0.000214	0.00147	CcSEcCtD
Cyclobenzaprine—Vomiting—Galantamine—Alzheimer's disease	0.000214	0.00147	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000213	0.00146	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Memantine—Alzheimer's disease	0.000212	0.00146	CcSEcCtD
Cyclobenzaprine—Rash—Galantamine—Alzheimer's disease	0.000212	0.00145	CcSEcCtD
Cyclobenzaprine—Dermatitis—Galantamine—Alzheimer's disease	0.000212	0.00145	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Memantine—Alzheimer's disease	0.000211	0.00145	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000211	0.00145	CcSEcCtD
Cyclobenzaprine—Headache—Galantamine—Alzheimer's disease	0.000211	0.00144	CcSEcCtD
Cyclobenzaprine—Somnolence—Memantine—Alzheimer's disease	0.00021	0.00144	CcSEcCtD
Cyclobenzaprine—Insomnia—Rivastigmine—Alzheimer's disease	0.000209	0.00144	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Memantine—Alzheimer's disease	0.000208	0.00143	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000208	0.00143	CcSEcCtD
Cyclobenzaprine—Urticaria—Donepezil—Alzheimer's disease	0.000207	0.00142	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000206	0.00142	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Donepezil—Alzheimer's disease	0.000206	0.00141	CcSEcCtD
Cyclobenzaprine—Somnolence—Rivastigmine—Alzheimer's disease	0.000206	0.00141	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Memantine—Alzheimer's disease	0.000206	0.00141	CcSEcCtD
Cyclobenzaprine—Fatigue—Memantine—Alzheimer's disease	0.000204	0.0014	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000204	0.0014	CcSEcCtD
Cyclobenzaprine—Constipation—Memantine—Alzheimer's disease	0.000202	0.00139	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000201	0.00138	CcSEcCtD
Cyclobenzaprine—Nausea—Galantamine—Alzheimer's disease	0.0002	0.00137	CcSEcCtD
Cyclobenzaprine—Fatigue—Rivastigmine—Alzheimer's disease	0.0002	0.00137	CcSEcCtD
Cyclobenzaprine—Constipation—Rivastigmine—Alzheimer's disease	0.000198	0.00136	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Memantine—Alzheimer's disease	0.000195	0.00134	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000193	0.00133	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000192	0.00132	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000191	0.00131	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000189	0.0013	CcSEcCtD
Cyclobenzaprine—Urticaria—Memantine—Alzheimer's disease	0.000188	0.00129	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Memantine—Alzheimer's disease	0.000187	0.00128	CcSEcCtD
Cyclobenzaprine—Asthenia—Donepezil—Alzheimer's disease	0.000187	0.00128	CcSEcCtD
Cyclobenzaprine—Pruritus—Donepezil—Alzheimer's disease	0.000184	0.00126	CcSEcCtD
Cyclobenzaprine—Urticaria—Rivastigmine—Alzheimer's disease	0.000184	0.00126	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR6—Alzheimer's disease	0.000183	0.0414	CrCbGaD
Cyclobenzaprine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000183	0.00125	CcSEcCtD
Cyclobenzaprine—Promethazine—CALM1—Alzheimer's disease	0.000181	0.0408	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR6—Alzheimer's disease	0.00018	0.0406	CrCbGaD
Cyclobenzaprine—Protriptyline—SLC6A4—Alzheimer's disease	0.00018	0.0406	CrCbGaD
Cyclobenzaprine—Diarrhoea—Donepezil—Alzheimer's disease	0.000178	0.00122	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Memantine—Alzheimer's disease	0.000174	0.0012	CcSEcCtD
Cyclobenzaprine—Dizziness—Donepezil—Alzheimer's disease	0.000172	0.00118	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000171	0.00117	CcSEcCtD
Cyclobenzaprine—Asthenia—Memantine—Alzheimer's disease	0.00017	0.00116	CcSEcCtD
Cyclobenzaprine—Pruritus—Memantine—Alzheimer's disease	0.000167	0.00115	CcSEcCtD
Cyclobenzaprine—Asthenia—Rivastigmine—Alzheimer's disease	0.000166	0.00114	CcSEcCtD
Cyclobenzaprine—Vomiting—Donepezil—Alzheimer's disease	0.000166	0.00114	CcSEcCtD
Cyclobenzaprine—Rash—Donepezil—Alzheimer's disease	0.000164	0.00113	CcSEcCtD
Cyclobenzaprine—Dermatitis—Donepezil—Alzheimer's disease	0.000164	0.00113	CcSEcCtD
Cyclobenzaprine—Pruritus—Rivastigmine—Alzheimer's disease	0.000164	0.00112	CcSEcCtD
Cyclobenzaprine—Headache—Donepezil—Alzheimer's disease	0.000163	0.00112	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Memantine—Alzheimer's disease	0.000162	0.00111	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR6—Alzheimer's disease	0.000161	0.0365	CrCbGaD
Cyclobenzaprine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000158	0.00109	CcSEcCtD
Cyclobenzaprine—Dizziness—Memantine—Alzheimer's disease	0.000156	0.00107	CcSEcCtD
Cyclobenzaprine—Nausea—Donepezil—Alzheimer's disease	0.000155	0.00106	CcSEcCtD
Cyclobenzaprine—Dizziness—Rivastigmine—Alzheimer's disease	0.000153	0.00105	CcSEcCtD
Cyclobenzaprine—Vomiting—Memantine—Alzheimer's disease	0.00015	0.00103	CcSEcCtD
Cyclobenzaprine—Rash—Memantine—Alzheimer's disease	0.000149	0.00102	CcSEcCtD
Cyclobenzaprine—Dermatitis—Memantine—Alzheimer's disease	0.000149	0.00102	CcSEcCtD
Cyclobenzaprine—Headache—Memantine—Alzheimer's disease	0.000148	0.00102	CcSEcCtD
Cyclobenzaprine—Vomiting—Rivastigmine—Alzheimer's disease	0.000147	0.00101	CcSEcCtD
Cyclobenzaprine—Rash—Rivastigmine—Alzheimer's disease	0.000146	0.001	CcSEcCtD
Cyclobenzaprine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000146	0.001	CcSEcCtD
Cyclobenzaprine—Headache—Rivastigmine—Alzheimer's disease	0.000145	0.000995	CcSEcCtD
Cyclobenzaprine—Nausea—Memantine—Alzheimer's disease	0.000141	0.000964	CcSEcCtD
Cyclobenzaprine—Nausea—Rivastigmine—Alzheimer's disease	0.000138	0.000943	CcSEcCtD
Cyclobenzaprine—Protriptyline—CYP2D6—Alzheimer's disease	0.000126	0.0285	CrCbGaD
Cyclobenzaprine—Imipramine—HTR6—Alzheimer's disease	0.000126	0.0284	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR6—Alzheimer's disease	0.000125	0.0282	CrCbGaD
Cyclobenzaprine—Tripelennamine—CYP2D6—Alzheimer's disease	0.000113	0.0256	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR2A—Alzheimer's disease	7.81e-05	0.0177	CrCbGaD
Cyclobenzaprine—Tamoxifen—ESR1—Alzheimer's disease	7.32e-05	0.0165	CrCbGaD
Cyclobenzaprine—Nortriptyline—PTGS1—Alzheimer's disease	7.11e-05	0.0161	CrCbGaD
Cyclobenzaprine—Nortriptyline—SLC6A4—Alzheimer's disease	6.88e-05	0.0156	CrCbGaD
Cyclobenzaprine—Diphenhydramine—PTGS1—Alzheimer's disease	6.57e-05	0.0149	CrCbGaD
Cyclobenzaprine—Trimipramine—SLC6A4—Alzheimer's disease	6.48e-05	0.0146	CrCbGaD
Cyclobenzaprine—Doxepin—SLC6A4—Alzheimer's disease	6.18e-05	0.014	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—Alzheimer's disease	5.39e-05	0.0122	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR2A—Alzheimer's disease	5.29e-05	0.012	CrCbGaD
Cyclobenzaprine—Trimipramine—HTR2A—Alzheimer's disease	4.98e-05	0.0113	CrCbGaD
Cyclobenzaprine—Nortriptyline—CYP2D6—Alzheimer's disease	4.84e-05	0.0109	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A4—Alzheimer's disease	4.81e-05	0.0109	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—Alzheimer's disease	4.8e-05	0.0108	CrCbGaD
Cyclobenzaprine—Amitriptyline—SLC6A4—Alzheimer's disease	4.78e-05	0.0108	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—Alzheimer's disease	4.75e-05	0.0107	CrCbGaD
Cyclobenzaprine—Trimipramine—CYP2D6—Alzheimer's disease	4.55e-05	0.0103	CrCbGaD
Cyclobenzaprine—Diphenhydramine—CYP2D6—Alzheimer's disease	4.47e-05	0.0101	CrCbGaD
Cyclobenzaprine—Promethazine—CYP2D6—Alzheimer's disease	4.39e-05	0.00991	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP2D6—Alzheimer's disease	4.35e-05	0.00984	CrCbGaD
Cyclobenzaprine—Doxepin—CYP2D6—Alzheimer's disease	4.34e-05	0.00981	CrCbGaD
Cyclobenzaprine—Promazine—HTR2A—Alzheimer's disease	4.22e-05	0.00954	CrCbGaD
Cyclobenzaprine—Imipramine—HTR2A—Alzheimer's disease	3.69e-05	0.00835	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—Alzheimer's disease	3.67e-05	0.0083	CrCbGaD
Cyclobenzaprine—Imipramine—CYP2D6—Alzheimer's disease	3.38e-05	0.00764	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2D6—Alzheimer's disease	3.36e-05	0.00759	CrCbGaD
Cyclobenzaprine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	1.87e-05	0.00302	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	1.85e-05	0.00299	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	1.83e-05	0.00296	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	1.8e-05	0.0029	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GAL—Alzheimer's disease	1.78e-05	0.00287	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	1.73e-05	0.0028	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	1.68e-05	0.00271	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	1.61e-05	0.00259	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	1.6e-05	0.00259	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	1.56e-05	0.00252	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	1.5e-05	0.00242	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PYY—Alzheimer's disease	1.45e-05	0.00234	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	1.41e-05	0.00227	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	1.4e-05	0.00226	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—NPY—Alzheimer's disease	1.4e-05	0.00226	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	1.39e-05	0.00225	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—IAPP—Alzheimer's disease	1.39e-05	0.00224	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	1.39e-05	0.00224	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	1.36e-05	0.0022	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CRH—Alzheimer's disease	1.35e-05	0.00218	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—F2—Alzheimer's disease	1.34e-05	0.00216	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	1.33e-05	0.00216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PYY—Alzheimer's disease	1.32e-05	0.00213	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.32e-05	0.00213	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—NPS—Alzheimer's disease	1.28e-05	0.00206	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	1.25e-05	0.00202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—SST—Alzheimer's disease	1.22e-05	0.00197	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR6—Alzheimer's disease	1.21e-05	0.00195	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	1.2e-05	0.00194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	1.2e-05	0.00193	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—APP—Alzheimer's disease	1.19e-05	0.00192	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	1.18e-05	0.00191	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	1.16e-05	0.00187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CDK5—Alzheimer's disease	1.14e-05	0.00184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR6—Alzheimer's disease	1.1e-05	0.00178	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	1.09e-05	0.00176	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	1.08e-05	0.00175	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	1.05e-05	0.0017	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	1.04e-05	0.00169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	1.04e-05	0.00168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	1.03e-05	0.00167	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	1.03e-05	0.00166	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	1.02e-05	0.00164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	1.01e-05	0.00163	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	1.01e-05	0.00163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GAL—Alzheimer's disease	1.01e-05	0.00162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GAL—Alzheimer's disease	9.13e-06	0.00147	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	9.1e-06	0.00147	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TTR—Alzheimer's disease	8.9e-06	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	8.85e-06	0.00143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	8.84e-06	0.00143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—NPY—Alzheimer's disease	7.89e-06	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	7.89e-06	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCR5—Alzheimer's disease	7.85e-06	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—IAPP—Alzheimer's disease	7.85e-06	0.00127	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PYY—Alzheimer's disease	7.78e-06	0.00126	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CA4—Alzheimer's disease	7.74e-06	0.00125	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	7.71e-06	0.00125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CRH—Alzheimer's disease	7.62e-06	0.00123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	7.58e-06	0.00122	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	7.28e-06	0.00118	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—NPS—Alzheimer's disease	7.22e-06	0.00117	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.19e-06	0.00116	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NPY—Alzheimer's disease	7.17e-06	0.00116	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IAPP—Alzheimer's disease	7.12e-06	0.00115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CRH—Alzheimer's disease	6.92e-06	0.00112	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	6.9e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GAB2—Alzheimer's disease	6.89e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—SST—Alzheimer's disease	6.89e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDK5—Alzheimer's disease	6.74e-06	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—F2—Alzheimer's disease	6.74e-06	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—APP—Alzheimer's disease	6.71e-06	0.00108	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLD3—Alzheimer's disease	6.58e-06	0.00106	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NPS—Alzheimer's disease	6.56e-06	0.00106	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CA4—Alzheimer's disease	6.56e-06	0.00106	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PPP3CA—Alzheimer's disease	6.52e-06	0.00105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR6—Alzheimer's disease	6.49e-06	0.00105	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.41e-06	0.00104	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PLCB1—Alzheimer's disease	6.33e-06	0.00102	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	6.31e-06	0.00102	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—SST—Alzheimer's disease	6.26e-06	0.00101	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GAB2—Alzheimer's disease	6.26e-06	0.00101	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	6.16e-06	0.000996	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	6.11e-06	0.000988	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—APP—Alzheimer's disease	6.1e-06	0.000985	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	6.07e-06	0.000981	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CCL2—Alzheimer's disease	6.01e-06	0.00097	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.95e-06	0.000961	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PSENEN—Alzheimer's disease	5.89e-06	0.000952	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ND1—Alzheimer's disease	5.87e-06	0.000947	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	5.84e-06	0.000944	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APH1A—Alzheimer's disease	5.81e-06	0.000939	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PLCB1—Alzheimer's disease	5.75e-06	0.000929	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NCSTN—Alzheimer's disease	5.66e-06	0.000914	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLD3—Alzheimer's disease	5.57e-06	0.000901	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.57e-06	0.000901	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LRP1—Alzheimer's disease	5.52e-06	0.000892	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.51e-06	0.00089	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAL—Alzheimer's disease	5.39e-06	0.000871	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GFAP—Alzheimer's disease	5.39e-06	0.000871	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	5.34e-06	0.000863	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.22e-06	0.000844	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	5.14e-06	0.000831	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA4—Alzheimer's disease	5.06e-06	0.000817	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ND1—Alzheimer's disease	4.97e-06	0.000803	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.86e-06	0.000784	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.76e-06	0.000769	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—A2M—Alzheimer's disease	4.75e-06	0.000768	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	4.73e-06	0.000764	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	4.68e-06	0.000757	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PSEN2—Alzheimer's disease	4.6e-06	0.000743	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.51e-06	0.000729	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.44e-06	0.000718	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CCR5—Alzheimer's disease	4.44e-06	0.000717	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.3e-06	0.000695	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCG—Alzheimer's disease	4.25e-06	0.000687	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPY—Alzheimer's disease	4.24e-06	0.000684	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IAPP—Alzheimer's disease	4.21e-06	0.00068	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.12e-06	0.000666	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CRH—Alzheimer's disease	4.09e-06	0.00066	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCR5—Alzheimer's disease	4.03e-06	0.000651	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.97e-06	0.000641	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPS—Alzheimer's disease	3.87e-06	0.000626	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP3CA—Alzheimer's disease	3.85e-06	0.000623	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.83e-06	0.000619	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.83e-06	0.000618	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—F2—Alzheimer's disease	3.81e-06	0.000615	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTK2B—Alzheimer's disease	3.8e-06	0.000614	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	3.78e-06	0.000611	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	3.78e-06	0.000611	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAB2—Alzheimer's disease	3.7e-06	0.000597	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SST—Alzheimer's disease	3.7e-06	0.000597	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NTRK2—Alzheimer's disease	3.7e-06	0.000597	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CALM1—Alzheimer's disease	3.68e-06	0.000594	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	3.66e-06	0.000592	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	3.62e-06	0.000585	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APP—Alzheimer's disease	3.6e-06	0.000582	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	3.49e-06	0.000563	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.49e-06	0.000563	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	3.46e-06	0.000559	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	3.4e-06	0.000549	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—A2M—Alzheimer's disease	3.37e-06	0.000544	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	3.2e-06	0.000517	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	3.2e-06	0.000517	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	3.17e-06	0.000512	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	3.15e-06	0.000509	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	3.1e-06	0.0005	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	3.08e-06	0.000498	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	3.07e-06	0.000496	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	2.95e-06	0.000477	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	2.93e-06	0.000473	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	2.93e-06	0.000473	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.92e-06	0.000472	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	2.9e-06	0.000468	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.89e-06	0.000468	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—A2M—Alzheimer's disease	2.85e-06	0.000461	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	2.79e-06	0.00045	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	2.75e-06	0.000444	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	2.75e-06	0.000444	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	2.7e-06	0.000435	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	2.58e-06	0.000417	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	2.56e-06	0.000414	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	2.55e-06	0.000412	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.54e-06	0.000411	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	2.51e-06	0.000406	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	2.48e-06	0.000401	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.47e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.47e-06	0.000399	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	2.45e-06	0.000396	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	2.45e-06	0.000395	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.41e-06	0.000389	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	2.38e-06	0.000385	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.37e-06	0.000383	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.34e-06	0.000377	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	2.33e-06	0.000376	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	2.33e-06	0.000376	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	2.28e-06	0.000369	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.28e-06	0.000368	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.2e-06	0.000356	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	2.17e-06	0.000351	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	2.17e-06	0.00035	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	2.17e-06	0.00035	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.16e-06	0.000349	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	2.15e-06	0.000347	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	2.07e-06	0.000334	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	2.04e-06	0.00033	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.04e-06	0.00033	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.01e-06	0.000325	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2e-06	0.000324	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2e-06	0.000323	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2e-06	0.000323	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	1.98e-06	0.00032	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.92e-06	0.00031	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.89e-06	0.000306	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.88e-06	0.000303	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.86e-06	0.000301	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.85e-06	0.000299	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.83e-06	0.000296	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.82e-06	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.8e-06	0.00029	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.8e-06	0.00029	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.79e-06	0.000289	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.76e-06	0.000284	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.7e-06	0.000275	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.7e-06	0.000274	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.67e-06	0.00027	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.65e-06	0.000266	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.62e-06	0.000262	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.58e-06	0.000254	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.55e-06	0.000251	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.54e-06	0.000249	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.54e-06	0.000248	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.53e-06	0.000247	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.52e-06	0.000246	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.4e-06	0.000226	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.39e-06	0.000225	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.38e-06	0.000223	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.37e-06	0.000221	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.34e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.32e-06	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.31e-06	0.000212	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.31e-06	0.000212	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.31e-06	0.000211	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.3e-06	0.00021	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.29e-06	0.000208	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.27e-06	0.000205	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.26e-06	0.000204	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.2e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.17e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.15e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.13e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.11e-06	0.00018	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.08e-06	0.000174	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.07e-06	0.000173	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.01e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.95e-07	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	9.75e-07	0.000157	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	8.92e-07	0.000144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	8.83e-07	0.000143	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.75e-07	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—Alzheimer's disease	8.58e-07	0.000139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.09e-07	0.000131	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.52e-07	0.000122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.46e-07	0.000121	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.88e-07	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.29e-07	8.54e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.48e-07	7.24e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.46e-07	5.59e-05	CbGpPWpGaD
